Research Models

Tg2576/Tau(P301L) (APPSwe-Tau)

Synonyms: APPSwe(2576)/TauJNPL3, TAPP

Tools

Back to the Top

Species: Mouse
Genes: APP, MAPT
Mutations: APP K670_M671delinsNL (Swedish), MAPT P301L
Modification: APP; MAPT: Transgenic
Disease Relevance: Alzheimer's Disease
Strain Name: Tg(APPSWE)2576Kha; Tg(Prnp-MAPT*P301L)JNPL3Hlmc
Genetic Background: C57BL/6, DBA/2, SJL, SW Mixed Background
Availability: Taconic: Stock# 2469

Summary

These mice were made by crossing mice that develop extensive plaque pathology (Tg2576) with a line that develops neurofibrillary tangles (JNPL3). The resulting bigenic mice develop plaque pathology similar to Tg2576 animals, but more extensive neurofibrillary tangles than the JNPL3. The levels of total soluble endogenous and transgenic tau protein and tau mRNA were similar in the brains of bigenic mice and JNPL3 mice (Lewis et al., 2001). Neuropathologically, the mice exhbit a gradual appearance of plaques. By nine months plaques are scattered throughout the cortex, hippocampus, and amygdala similar to Tg2576. Astrocytosis and microgliosis are also observed. Behaviorally, the mice exhibit motor disturbances similar to JNPL3, with a comparable range in onset. They also show reduced vocalization and decreased grooming. In addition, progressive hindlimb weakness and a hunched posture have been noted. Eye irritations are also common. Some mice have the Pde6brd1 retinal degeneration mutation which can cause light sensitivity and/or blindness and may affect behavioral testing.

Modification Details

Generated by crossing Tg2576 mice, which have the transgene for human APP (isoform 695) carrying the Swedish mutation with JNPL3 mice expressing human MAPT (4 repeat) with the P301L mutation.

Phenotype Characterization

When visualized, these models will distributed over a 18 month timeline demarcated at the following intervals: 1mo, 3mo, 6mo, 9mo, 12mo, 15mo, 18mo+.

Absent

No Data

  • Synaptic Loss

Plaques

Plaques develop gradually with age. No plaques at 5 months. Very few small plaques at 6 and 7 months. By 9 months plaques scattered throughout the cortex, hippocampus and amygdala, continue to increase at 12 months. Similar distribution as Tg2576.

Tangles

Neurofibrillary tangles in the spinal cord and pons as early as 3 months, but more consistent and numerous by 6 months. Tangles morphologically similar to those in JNPL3 mice but older bigenic female mice had a marked increase in neurofibrillary tangles in limbic areas by 6 months, especially the olfactory cortex, entorhinal cortex and amygdala (Lewis et al., 2001).

Gliosis

Reactive astrocytes and microglia as early as 3 months in the hippocampus as measured by GFAP and CD45. Increased astrocytosis with age especially in limbic areas with the most neurofibrillary tangles. Microglia especially concentrated around plaques at 9 and 12 months (Lewis et al., 2001).

Synaptic Loss

Unknown.

Last Updated: 25 Nov 2019

COMMENTS / QUESTIONS

No Available Comments

Make a comment or submit a question

To make a comment you must login or register.

References

Research Models Citations

  1. Tg2576
  2. JNPL3(P301L)

Paper Citations

  1. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, Yen SH, Sahara N, Skipper L, Yager D, Eckman C, Hardy J, Hutton M, McGowan E. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001 Aug 24;293(5534):1487-91. PubMed.

External Citations

  1. Taconic: Stock# 2469

Further Reading